| impurities list of API molecules | |||||||||||||
|
|||||||||||||
| 58. | Cobicistate |
|
|
|
|
|||||||||||
| 59. | Cobicistat |
|
(Thiazol-5-yl)methyl methyl(2S,5S)-1,6-diphenyl-5-(urea)hexan-2-ylcarbamate |
|
|
|||||||||||
| 60. | Cobicistat |
|
|
|
|
|||||||||||
| 61. | Cobicistate |
|
3-((S)-1-(N-((2-Isopropylthiazol-5-yl)methyl)-N-methyl |
|
|
|||||||||||
| 62. | Clopidogrel |
|
(2S) (+) -(2-Chlorophenyl)-2(6.7-dihydro-4H-thieno- [3,2-c] pyridine-5-yl)-2-acetic acid |
144457-28-3 |
IMP-A (USP RC-A) |
|||||||||||
| 63. | Citalopram HBr |
|
Citalopram HBr N-oxide |
|
N-Oxide |
|||||||||||
| 64. | Citalopram |
|
(1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-yl)(4-fluorophenyl)methanone |
|
4-Phenylketo imp |
|||||||||||
| 65. | Citalopram |
|
4-(Dimethylamino)-1-((R)-1-(3- |
|
Impurity – EP Imp-G (Dimethylamino |
|||||||||||
| 66. | Citalopram.HBr |
|
1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxylic acid |
|
Acid |
|||||||||||
| 67. | Citalopram.HBr |
|
Methyl 1-(3-(dimethylamino) |
|
Methyl ester |
|||||||||||
| 68. | Citalopram.HCl |
|
1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide |
|
Carboxamide Imp |
|||||||||||
| 69. | Citalopram.HCl |
|
3-(5-Chloro-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl)-N,N-dimethylpropan-1-amine |
|
Chloro imp |
|||||||||||
| 70. | Citalopram |
|
1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-3-oxoisobenzofuran-5-carbonitrile hydrobromide |
|
Oxo Impurity |
|||||||||||
| 71. | Clarithromycin |
|
6-O-MethylerythroMycin (9E)-9-(O-MethyloxiMe) |
127182-44-9 |
IMP-G |
|||||||||||
| 72. | Clarithromycin |
|
|
|
IMP-N |
|||||||||||
| 73. | Ciprofloxacin |
|
7-(2-Aminoethylamino)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid |
|
EDA (Enrofloxacin EDA) |
|||||||||||
| 74. | Dabigatran Etexilate Mesylate |
|
[(4-Amino-phenyl)-imino-methyl]-carbamic acid hexyl ester |
|
IH(IMP-1) |
|||||||||||
| 75. | Dabigatran Etexilate Mesylate |
|
2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzoimidazole-5-carboxylic acid ethyl ester |
|
IH(IMP-2) |
|||||||||||
| 76. | Dabigatran Etexilate Mesylate |
|
3-[(2-{[4-(Hexyloxycarbonyl |
|
IH(IMP-3) |
|||||||||||
| 77. | Dabigatran Etexilate Mesylate |
|
3-[(2-{[4-(Hexyloxycarbonyl |
|
IH(IMP-4) |
|||||||||||
| 78. | Dabigatran Etexilate Mesylate |
|
3-({2-[(4-Hexyloxycarbonyl |
|
IH(IMP-5) |
|||||||||||
| 79. | Dabigatran Etexilate Mesylate |
|
{[4-({5-[(2-Carbamoyl-ethyl)-pyridin-2-yl-carbamoyl]-1-methyl-1H-benzoimidazol-2-ylmethyl}-amino)- |
|
IH(IMP-6) |
|||||||||||
| 80. | Dabigatran Etexilate Mesylate |
|
3-[(2-{[4-(Hexyloxycarbonyl |
|
IH(IMP-7) |
|||||||||||
| 81. | Dabigatran Etexilate Mesylate |
|
3-[(2-{[4-(Imino-propionyl |
|
IH(IMP-8) |
|||||||||||
| 82. | Dabigatran Etexilate Mesylate |
|
(Imino-{4-[(1-methyl-5-{pyridin-2-yl-[2-(pyridin-2-ylcarbamoyl)-ethyl]-carbamoyl}-1H-benzoimidazol-2-ylmethyl)- |
|
IH(IMP-9) |
|||||||||||
| 83. | Dabigatran Etexilate Mesylate |
|
({4-[(5-Carbamoyl-1-methyl-1H-benzoimidazol-2-ylmethyl)-amino]-phenyl}-imino-methyl)-carbamic acid hexyl ester |
|
IH(IMP-10) |
|||||||||||
| 84. | Dabigatran Etexilate Mesylate |
|
3-({2-[(4-Carbamoyl-phenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)propionic acid ethyl ester |
|
IH(IMP-11) |
|||||||||||
| 85. | Dexlansoprazole |
|
2-Mercapto benzimidazole |
583-39-1 |
|
|||||||||||
| 86. | Dexlansoprazole |
|
2-((3-methyl-4-(methylsulfonyl)pyridin-2-yl)methylsulfonyl)-1H-benzo |
|
DXL-II Sulfone impurity |
|||||||||||
| 87. | Dexlansoprazole |
|
2-((4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-yl)methyl |
|
S-isomer |
|||||||||||
| 88. | Dexlansoprazole |
|
2,3-dimethyl-4-(methylsulfonyl)pyridine |
|
Deschloro Impurity |
|||||||||||
| 89. | Dexlansoprazole (Lansoprazole) |
|
2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole 1’-oxide. |
N/A |
Sulfone N-Oxide |
|||||||||||
| 90. | Dexlansoprazole |
|
1-Methyl-10-thioxo-10H-4a,5,9b-triaza-indeno[2,1-a]inden-2-one |
|
Indenone Impurity |
|||||||||||
| 91. | Duloxetin |
|
(1S)-3-(Methylamino)-1-(thiophen-2-yl)propan-1-ol |
116539-55-0 |
USP Imp-B |
|||||||||||
| 92. | Duloxetin |
|
2-[(1RS)-3-(Methylamino)-1-(thiophen-2-yl)propyl] |
|
USP Imp-E |
|||||||||||
| 93. | Desloratadine |
|
Iso Desloratadine |
183198-49-4 |
IMP-B |
|||||||||||
|
||||||||||||||||